SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-043385
Filing Date
2020-12-18
Accepted
2020-12-18 08:31:58
Documents
15
Period of Report
2020-12-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131880-8k_ziopharm.htm   iXBRL 8-K 82751
2 PRESS RELEASE OF ZIOPHARM ONCOLOGY, INC., DATED DECEMBER 16, 2020 ea131880ex99-1_ziopharmonco.htm EX-99.1 10788
3 NOTICE TO STOCKHOLDERS OF ZIOPHARM ONCOLOGY, INC., DATED DECEMBER 18, 2020 ea131880ex99-2_ziopharmonco.htm EX-99.2 4845
4 GRAPHIC ex99-1_001.jpg GRAPHIC 11423
  Complete submission text file 0001213900-20-043385.txt   307582

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ziop-20201215.xsd EX-101.SCH 3209
6 XBRL LABEL FILE ziop-20201215_lab.xml EX-101.LAB 35263
7 XBRL PRESENTATION FILE ziop-20201215_pre.xml EX-101.PRE 23158
8 EXTRACTED XBRL INSTANCE DOCUMENT ea131880-8k_ziopharm_htm.xml XML 4024
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 201398071
SIC: 2834 Pharmaceutical Preparations